$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

In vitro Transport of Fexofenadine.HCl in Deformable Liposomes Across the Human Nasal Epithelial Cell Monolayers 원문보기

藥劑學會誌 = Journal of Korean pharmaceutical sciences, v.34 no.6, 2004년, pp.483 - 489  

Lin, Hong-Xia (College of Pharmacy, Pusan National university) ,  Lee, Chi-Ho (College of Pharmacy, Pusan National university) ,  Shim, Chang-Koo (College of Pharmacy, Seoul National University) ,  Chung, Suk-Jae (College of Pharmacy, Seoul National University) ,  Kim, Dae-Duk (College of Pharmacy, Seoul National University)

Abstract AI-Helper 아이콘AI-Helper

Fexofenadine HCl is non-sedating histamine H1 receptor antagonist that can be used for the treatment of seasonal allergic rhinitis. The objective of this study was to investigate whether the carriers of deformable liposomes can enhance the transepithelial permeability of fexofenadine HCl across the ...

주제어

AI 본문요약
AI-Helper 아이콘 AI-Helper

* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.

제안 방법

  • The samples of fexofenadine , HC1 were directly analyzed using an isocratic HPLC method on a Shimadzu HPLC system (SPD-10AV, Shimadzu Co., Kyoto, Japan) equipped with a pump and an automatic injector (SPD-10AVVP). A reversed phase C-18 column (Lichrospher® 100, RP-18, 125x4 mm, 5 ㎛, Merck Darmstadt, Germany) was used as stationary phase.
  • The transport studies were performed by initially incubating the monolayers in transport medium (HBSS supplemented with 15 mM 응hicose and 15 mM HEPES, pH 7.4) for 20 min at 37℃. Each transport experiment was performed by adding 0.

대상 데이터

  • The specimens were dehydrated through an alcohol series and allowed to air-dry overnight. The specimens were mounted on stubs with adhesive tape, sputter coated, and viewed in a Hitachi S-4200 scanning electron microscope (Hitachi, Japan).
본문요약 정보가 도움이 되었나요?

참고문헌 (19)

  1. C. Lippert, J. Ling, P. Brown, S. Burmaster, M. Eller, L. Cheng, R. Thompson and S. Weir, Mass balance and pharmacokinetics of MDLl6445A in healthy male volunteers, Pharm. Res., 12, S390 (1995). 

  2. S. Turker, E. Onur E. and Y. Ozer, Nasal route and drug delivery systems, Pharm. World Sci., 26, 137-42 (2004) 

  3. P. Arora, S. Sharma and S. Garg, Permeability issues in nasal drug delivery, Drug Discovery Today, 7, 967-975 (2002) 

  4. T. Kissel and U. Werner, Nasal delivery of peptides: an in vitro cell culture model for the investigation of transport and metabolism in human nasal epithelium, J. Con. Rel., 53, 195-203 (1998) 

  5. M.K. Lee, J.W. Yoo, H. Lin, D.D. Kim and H.J. Roh, Serially passaged human nasal epithelial cell monolayer for drug transport studies: Comparison between liquid-cover condition (LCC) and air-liquid interface (ALI) culture condition, submitted for publication in Int. J. Pharm 

  6. W.J. Irwin, A.K. Dwivedi, P.A. Holbrook and M. J. Dey, The effect of cyclodextrins on the stability of peptides in nasal enzymatic systems, Pharm. Res., 11, 1698-1703 (1994) 

  7. K.I. Hosoya, H. Kubo, H. Natsume, K. Sugibayashi and Y. Morimoto, Evaluation of enhancers to increase nasal absorption using Ussing chamber technique, BioI. Pharm. Bull., 17, 316-322 (1994) 

  8. F.W.H.M. Merkus, J.C. Verhoef, E. Marttin, S.G. Romeijn, P.H.M. van der Kuy, W.A.J.J. Hermens and N.G.M. Schipper, Cyclodextrins in nasal drug delivery, Adv. Drug Del. Rev., 36, 41-57 (1999) 

  9. K. Morimoto, H. Katsumata, T. Yabuta, K. Iwanaga, M. Kakemi, Y. Tabata and Y. Ikada, Design of gelatinmicrospheres for pulmonary, nasal and intramuscular administrations of salmon-calcitonin, Proceedings of the 26th international symposium on controlled release of bioactive materials, Controlled Release Society, pp. 307-308 (1999) 

  10. S.S. Davis and L. Illum, Absorption enhancers for nasal drug delivery, Clin. Pharm., 42, 1107-1128 (2003) 

  11. G. Cevc and G. Blume, Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force, Biochim. Biophys. Acta, 1104, 226-32 (1992) 

  12. G. Cevc, Deformable liposomes, liposomes and other lipid suspensions on the skin: permeation enhancement, vesicle penetration, and transdermal drug delivery, Crit. Rev. Ther. Drug Carrier Syst., 13, 257-388 (1996) 

  13. S.I. Simoes, C.M. Marques, M.E.M. Cruz, G. Cevc and M.B.E Martins, The effect of cholate on solubilisation and permeability of simple and protein-loaded phosphatidylcholine/sodium cholate mixed aggregates designed to mediate transdermal delivery of macromolecules, Eur. J. Pharm. Biopharm., 58, 509-519 (2004) 

  14. R.U. Agu, M. Jorissen, R. Kinget, N. Verbeke and P. Augustijns, Alternatives to in vivo nasal toxicological screening for nasally-administered drugs, S.T.P. Pharm. Sci., 12, 13-22 (2002) 

  15. J. D. Kilgour, S.A. Simpson, D.J. Alexander and C.J. Reed, A rat nasal epithelial model for predicting upper respiratory tract toxicity: in vivo-in vitro correlations, Toxicology, 145, 39-49 (2000) 

  16. R.G. Rengel, K Barisic, Z. Pavelic, T.Z. Grubisic, I. Cepelak and J.F Grcic, High efficiency entrapment of superoxide dismutase into mucoadhesive chitosan-coated liposomes, Eur. J. Pharm. Sci., 15, 441-448 (2002) 

  17. S. Prior, B. Gander, N. Blarer, H.P. Merkle, M.L. Subria, J.M. Irache and C. Gamazo, In vitro phagocytosis and monocytemacrophage activation with poly (lactide) and poly (lactide-coglycolide) microphere, Eur. J. Pharm. Sci., 15, 197-207 (2002) 

  18. N.R. Mathias, K.J. Kim, T.W. Robison and Y.H. Lee, Development and characterization of rabbit tracheal epithelial cell monolayer models for drug transport studies, Pharm. Res., 12, 1499-1505 (1995) 

  19. N. W. Shappell, Ergovaline toxicity on Caco-2 cells as assessed by MTT, alamarBlue, and DNA assays, In Vitro Cell Dev. Bioi. Anim., 39, 329-35 (2003) 

저자의 다른 논문 :

관련 콘텐츠

섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로